Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

PAREXEL INTERNATIONAL CORPORATION (PRXL)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. engages in the provision of biopharmaceutical outsourcing services.

It operates through the following segments: Clinical Research Services, PAREXEL Consulting, and PAREXEL Informatics.

The Clinical Research Services segment includes clinical trials management and biostatistics, data management and clinical pharmacology, as well as related medical advisory, patient recruitment, clinical supply and drug logistics, pharmacoviligance, and investigator site services.

The PAREXEL Consulting segment focuses on technical expertise and advice in such areas as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance.

The PAREXEL Informatics segment offers information technology solutions designed to help improve client's product development, and regulatory submission processes.

The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA631983Chief Executive Officer & Director
Mark A. Goldberg, MD581997President & Chief Operating Officer
Simon John Harford, MBA572017Chief Financial Officer & Senior Vice President
Sy Pretorius MD, MBA482010Chief Scientific Officer & Senior Vice President
Jeremy Gelber-2017Director
Mark Stephenson--VP-Corporate Communications
Douglas Alexander Batt582006Secretary, Senior Vice President & General Counsel
Gadi Saarony502003Senior Vice President-Clinical Research Services
Roland Andersson, PhD542014Senior Vice President-Clinical Research Services
David J. Godwin, MBA--Senior Vice President-Global Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 51,115,310 50,131,867 98.1% 0 0.0% 98.1%
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL CORPORATION0.00%0
CELLTRION, INC.--.--%34 924
IQVIA HOLDINGS INC6.93%21 157
LONZA GROUP-7.82%19 259
INCYTE CORPORATION-6.91%18 046
NEKTAR THERAPEUTICS40.66%13 138
ALNYLAM PHARMACEUTICALS, INC.-5.56%11 881
ALKERMES PLC8.33%10 343
QIAGEN6.79%7 897
SEATTLE GENETICS, INC.1.05%7 841
SAGE THERAPEUTICS INC-0.67%6 666
IONIS PHARMACEUTICALS INC-3.90%6 239
ICON PLC1.52%6 215
GALAPAGOS17.12%5 851
UNITED THERAPEUTICS CORPORATION-7.46%5 830
EXACT SCIENCES CORPORATION-6.59%5 748
PRA HEALTH SCIENCES INC-2.09%5 634
BIO-TECHNE CORP8.88%5 290
CHARLES RIVER LABORATORIES INTL. INC0.79%5 128
FIBROGEN INC18.99%4 644
BB BIOTECH AG6.51%4 111
Connections : PAREXEL International Corp
New England Healthcare Institute
Pamplona Capital Management LLP
Harvard T.H. Chan School of Public Health
Boston Millennia Partners
PAREXEL Informatics, Inc.
© 2018 People , Fundamentals and Ownership